URGENT: This Altcoin Opportunity Won’t Wait – Act Now

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Teresa DeLuca Biography and Net Worth

Director of Surgery Partners

Dr. Teresa DeLuca M.D. serves as Independent Director of the Company. Dr. DeLuca has served as a Managing Director at Columbia University's NY Life Science Venture Fund since January 2018. She previously served as Assistant Clinical professor of psychiatry at the Icahn School of Medicine at Mount Sinai in New York City from 2014 to 2017 and as the Chief Medical Officer of Magellan Pharmacy Solutions at Magellan Health from 2012 to 2014. Prior to that, she served as SVP of Pharmacy Health Solutions at Humana, VP of Clinical Sales Solutions & National Medical Director at Walgreen Co., and VP of Personalized Medicine as well as VP of Medical Policy & Clinical Quality at Medco. Prior to taking on these executive leadership roles, Dr. DeLuca was a Senior Director of Global Product Development Services at PRA International and a Senior Medical Scientist at GlaxoSmithKline. Dr. DeLuca served as a director at North Bud Farms, Inc., a pharmaceutical company from May 2018 to February 2020. Dr. DeLuca received her M.B.A. from Drexel University and her residency (M.D.) from Jefferson Medical College of Thomas Jefferson University. Our Board believes that Dr. DeLuca is qualified to serve as a director based on, among other things, her healthcare knowledge, experience and skills gained from previously serving as a Chief Medical Officer. Additionally, a strong advocate for good board governance, in 2016 Dr. DeLuca earned both the Carnegie Mellon Cybersecurity certificate and continues to maintain good standing with the National Association of Corporate Directors (NACD) as a Board Leadership Fellow (Masters Level).

What is Teresa DeLuca's net worth?: The estimated net worth of Teresa DeLuca is at least $604,939.76 as of June 8th, 2021. Dr. DeLuca owns 28,508 shares of Surgery Partners stock worth more than $604,940 as of December 21st. This net worth evaluation does not reflect any other assets that Dr. DeLuca may own. Learn More about Teresa DeLuca's net worth.
How do I contact Teresa DeLuca?: The corporate mailing address for Dr. DeLuca and other Surgery Partners executives is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. Surgery Partners can also be reached via phone at (615) 234-5900 and via email at [email protected]. Learn More on Teresa DeLuca's contact information.
Has Teresa DeLuca been buying or selling shares of Surgery Partners?: Teresa DeLuca has not been actively trading shares of Surgery Partners within the last three months. Most recently, Teresa Deluca sold 1,535 shares of the business's stock in a transaction on Thursday, March 24th. The shares were sold at an average price of $53.50, for a transaction totalling $82,122.50. Learn More on Teresa DeLuca's trading history.
Who are Surgery Partners' active insiders?: Surgery Partners' insider roster includes Jennifer Baldock (Insider), Harrison Bane (President of the American Group), Marissa Brittenham (Chief Strategy Officer), Laura Brocklehurst (Insider), Danielle Burkhalter (Chief Human Resources Officer), Thomas Cowhey (CFO), Teresa DeLuca (Director), Wayne DeVeydt (Executive Chairman), David Doherty (CFO), Jason Evans (CEO), George Goodwin (Insider), Andrew Kaplan (Director), Bradley Owens (National Group President), Anthony Taparo (Insider), and Brent Turner (Director). Learn More on Surgery Partners' active insiders.
Are insiders buying or selling shares of Surgery Partners?: During the last twelve months, insiders at the sold shares 10 times. They sold a total of 30,774 shares worth more than $932,591.51. The most recent insider tranaction occured on June, 12th when insider Danielle Burkhalter sold 6,000 shares worth more than $158,340.00. Insiders at Surgery Partners own 2.3% of the company. Learn More about insider trades at Surgery Partners.
Information on this page was last updated on 6/12/2024.

Teresa DeLuca Insider Trading History at Surgery Partners

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/24/2022	Sell	1,535	$53.50	$82,122.50
8/10/2021	Buy	2,000	$46.70	$93,400.00
6/8/2021	Sell	2,633	$63.05	$166,010.65	28,508
12/4/2020	Sell	915	$27.75	$25,391.25	28,811
9/10/2020	Sell	3,000	$21.00	$63,000.00	28,811
8/10/2020	Sell	5,317	$20.60	$109,530.20	31,811
9/6/2019	Buy	1,000	$6.65	$6,650.00	27,459

Teresa DeLuca Buying and Selling Activity at Surgery Partners

Surgery Partners Company Overview

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Today's Range

Now: $21.22

$19.50

$21.36

50 Day Range

MA: $25.99

$19.61

$33.03

2 Week Range

Now: $21.22

$19.50

$35.29

Volume

1,643,492 shs

Average Volume

999,904 shs

Market Capitalization

$2.70 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.58